Coagulation Disorders in Cyanotic Congenital Heart Diseases: Surgical Implications
International Journal of Drug Delivery Technology · 01.06.2026 · 16 (39s)
DOI: 10.25258/ijddt.16.39s.39 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, erschienen am 01.06.2026. Verfasst von Mehak . und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Cyanotic congenital heart disease (CCHD) is an intricate congenital heart problem characterized by the passage of deoxygenated blood into the systemic circulation without passing through the lungs, resulting in chronic hypoxemia. In response, there is an increase in the number of red blood cells (secondary polycythemia), which causes the thickening of the blood and an imbalance in the normal processes of blood clotting. Thus, patients with CCHD are prone to develop both thrombosis and hemorrhage. Typical disorders include low platelets, dysfunctional platelets, low coagulation factors, enhanced fibrinolysis, and acquired von Willebrand disease. Performing surgery on such a patient, particularly when cardiopulmonary bypass is used, will further aggravate these problems due to hemodilution, inflammatory responses, and platelet activation.
Objective
For analyzing the pathophysiology of coagulation abnormalities in patients with cyanotic congenital heart disease, studying the various diagnostic tools used in assessing these diseases, and understanding the current management techniques of such patients during surgery using cardiopulmonary bypass is essential.
Methods
This systematic review analysed published clinical studies, observational research, trials, and reviews on coagulation disorders in CCHD patients undergoing surgery. Parameters assessed included haemoglobin, haematocrit, platelet count, PT, INR, aPTT, fibrinogen, and D-dimer. Point-of-care tests such as TEG and ROTEM were also reviewed. Intraoperative factors including CPB management, anticoagulation monitoring, and blood conservation methods like modified ultrafiltration and cell saver were evaluated. Preoperative optimization strategies such as correction of iron deficiency, thrombocytopenia management, and venesection for severe polycythaemia were also examined.
Result
Patients with CCHD showed clear coagulation abnormalities even before surgery. Common findings included raised haematocrit, thrombocytopenia, prolonged PT, INR, and aPTT, low fibrinogen levels, and deficiencies of clotting factors. Platelet dysfunction was also present in some patients despite normal platelet counts. During surgery, heparin resistance was frequently observed because polycythaemia reduced plasma volume, requiring higher heparin doses to achieve target ACT. After surgery, these patients had increased chest tube bleeding, higher blood transfusion requirements, more re-exploration procedures, and serious complications such as disseminated intravascular coagulation (DIC). The severity of abnormalities increased with higher polycythaemia, longer duration of cyanosis, and advanced pulmonary vascular disease. TEG- and ROTEM-guided transfusion strategies were more effective than empirical treatment in reducing blood product use and improving outcomes.
Conclusion
Coagulation disorders in CCHD are multifactorial and clinically important. Effective management requires preoperative hematological assessment, careful intraoperative perfusion strategies with modified ultrafiltration and tranexamic acid, and postoperative viscoelastic monitoring. A multidisciplinary team is essential to balance the risks of thrombosis and bleeding in these patients.
Zitieren
APA
., M., Chowdhury, U. K., Dubey, P., Biju, A., & Khatri, R. (2026). Coagulation Disorders in Cyanotic Congenital Heart Diseases: Surgical Implications. International Journal of Drug Delivery Technology, 16(39s). https://doi.org/10.25258/ijddt.16.39s.39
Vancouver
. M, Chowdhury UK, Dubey P, Biju A, Khatri R. Coagulation Disorders in Cyanotic Congenital Heart Diseases: Surgical Implications. International Journal of Drug Delivery Technology. 2026;16(39s). doi:10.25258/ijddt.16.39s.39
BibTeX
@article{2026,
author = {., Mehak and Chowdhury, Ujjwal Kumar and Dubey, Priya and Biju, Aryasree and Khatri, Rachna},
title = {Coagulation Disorders in Cyanotic Congenital Heart Diseases: Surgical Implications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {39s},
doi = {10.25258/ijddt.16.39s.39}
}
EUVIMED